SavedAdd your journal

Journals / Eurasian Journal of Medical Investigation / 2022 / Cilt: 6 - Sayı: 2

Uric Acid & Cancer

Sabri BARUTÇA
Hatice YILMAZ
Pages
141–146
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Higher levels of UA seem to be closely related to oncogenesis, though more specifically designed extended studies are needed on the subject.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Uric acid (UA) (C5H4N4O3), is a heterocyclic compound with a molecular weight of 168.11 Da and, it’s the last product of purine metabolism in humans.
📊
Key Findings & Data:The relationship in-between UA and cancer is complex as UA has both anti-oxidant and pro-oxidant functions.
💡
Conclusion & Impact:Higher levels of UA seem to be closely related to oncogenesis, though more specifically designed extended studies are needed on the subject.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Uric acid (UA) (C5H4N4O3), is a heterocyclic compound with a molecular weight of 168.11 Da and, it’s the last product of purine metabolism in humans. The relationship in-between UA and cancer is complex as UA has both anti-oxidant and pro-oxidant functions. Due to its anti-oxidant function, it was proposed as a protector for cancer growth. Also the products of xanthine oxidoreductase (XOR) activity; reactive oxygen species (ROS), and UA induced immuno-inflammatory reaction and oxidative stress were proposed to have roles in carcinogenesis. In fact, ROS may activate the inflammation mediated cell proliferation, angiogenesis and metastasis related signal pathways and so may have a possible carcinogenic potential. So, UA may promote inflammation mediated oncogenesis by both ROS production and cell transcription and cytokine synthesis. Higher levels of UA seem to be closely related to oncogenesis, though more specifically designed extended studies are needed on the subject.

🔖

Cite This Article

BARUTÇA, S., YILMAZ, H. (2022). Uric Acid & Cancer. Eurasian Journal of Medical Investigation, Cilt: 6 - Sayı: 2, 141–146. https://ajindex.com/articles/508524

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta 2018;484:150–63
  2. Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 2006;8:S1
  3. Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, et al. Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci 2014;18:1295– 306
  4. Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med 2013;3:208–20
  5. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016;213:8–14
  6. Battelli MG, Bortolotti M, Polito L, Bolognesi A. The role of xanthine oxidoreductase and uric acid in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis 2018;1864:2557–65
  7. Linder N, Rapola J, Raivio KO. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest 1999;79:967–74
  8. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purinerich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093–103
  9. Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002;19:640–53
  10. Schlesinger N, Brunetti L. Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol. Semin Arthritis Rheum 2020;50:444–50
  11. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005;11:4145–51
  12. Kang DH, Ha SK. Uric acid puzzle: dual role as anti-oxidantand pro-oxidant. Electrolyte Blood Press 2014;12:1–6
  13. Yan S, Zhang P, Xu W, Liu Y, Wang B, Jiang T, et al. Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis. Mediators Inflamm. 2015;2015:764250
  14. Battelli MG, Bortolotti M, Polito L, Bolognesi A. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase. Redox Biol 2019;21:101070
  15. Ben Salem C, Slim R, Fathallah N, Hmouda H. Drug-induced hyperuricaemia and gout. Rheumatology (Oxford) 2017;56:679– 88
  16. Wang W, Xu D, Wang B, Yan S, Wang X, Yin Y, et al. Increased risk of cancer in relation to gout: a review of three prospective cohort studies with 50,358 subjects. Mediators Inflamm 2015;2015:680853
  17. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid in